Aclaris Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $1.6 | $2 | $3.3 | $1.8 | $1.5 | $4.3 | $2.8 | $2.4 | |
| −$22 | −$20 | −$15 | −$15 | −$15 | −$7.6 | −$11 | −$17 | |
| −$0.15 | −$0.15 | −$0.12 | −$0.13 | −$0.12 | −$0.11 | −$0.15 | −$0.24 | |
| 143 | 129 | 123 | 123 | 122 | 71 | 71 | 71 |
Trend